| No. | Substance name | EC No. | CAS No. | Proposed Market | Reason for proposal |
| 1 | (±)-1,7,7-trimethyl-3-[(4-methylphenyl)methylene]bicyclo[2.2.1]heptan-2-one covering any of the individual isomers and/or combinations thereof (4-MBC)
(±)-1,7,7-Trimethyl-3-[(4-methylphenyl)methylene]bicyclo[2.2.1]heptan-2-one, including individual isomers and/or combinations thereof (4-MBC) | – | – | Denmark | Endocrine-disrupting properties
(Article 57(f) - Human Health) |
| 2 | 6,6′-di-tert-butyl-2,2′-methylenedi-p-cresol (DBMC)
6,6’雙二叔丁基-2,2′-亞甲基雙對甲酚 (DBMC) | 204-327-1 | 119-47-1 | Denmark | Reproductive toxicity
(第57條c) |
| 3 | S-(tricyclo[5.2.1.0’2,6]deca-3-en-8(or 9)-yl) O-(isopropyl or isobutyl or 2-ethylhexyl) O-(isopropyl or isobutyl or 2-ethylhexyl) phosphorodithioate
硫-(三環[5.2.1.0’2,6]癸-3-烯-8(或9)-基) 氧-(異丙基或異丁基或2-乙基己基) 氧-(異丙基或異丁基或2-乙基己基)二硫代磷酸酯 | 401-850-9 | 255881-94-8 | Belgium | Persistence, bioaccumulation and toxicity (PBT) (Article 57d) |
| 4 | tris(2-methoxyethoxy)vinylsilane
三(2-甲氧基乙氧基)乙烯基矽烷 | 213-934-0 | 1067-53-4 | Austria | Reproductive toxicity
(第57c條) |
